Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT1 | P35610 | 2/20 | 0.52 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 3/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | F7 | P08709 | 4/20 | 0.48 |
| ▸ | F3 | P13726 | 4/20 | 0.48 |
| ▸ | PPARG | P37231 | 4/20 | 0.48 |
| ▸ | PPARD | Q03181 | 4/20 | 0.48 |
| ▸ | PPARA | Q07869 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | FABP4 | P15090 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.48 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1259269 | 0.86 | SOAT2 (0.53) | SOAT1SOAT2FAAHEPHX2CNR1 | |
| SCHEMBL8612905 | 0.80 | EPHX2 (0.53) | SOAT1SOAT2FAAHEPHX2CNR1 | |
| SCHEMBL28224709 | 0.80 | SOAT1 (0.47) | SOAT1SOAT2FAAHEPHX2CNR1 | |
| SCHEMBL27794462 | 0.79 | SOAT2 (0.51) | SOAT1SOAT2FAAHEPHX2CNR1 | |
| SCHEMBL28005812 | 0.78 | FAAH (0.59) | SOAT1FAAHF7F3PPARG | |
| SCHEMBL9499436 | 0.78 | FAAH (0.59) | SOAT1FAAHF7F3PPARG | |
| SCHEMBL28469181 | 0.78 | CES2 (0.49) | EPHX2KDM4ELMNACYP3A4CYP2C9 | |
| SCHEMBL31603755 | 0.77 | FFAR1 (0.60) | SOAT1SOAT2FAAHEPHX2CNR1 | |
| SCHEMBL411307 | 0.77 | SOAT2 (0.58) | SOAT1SOAT2FAAHEPHX2ALDH1A1 | |
| SCHEMBL411308 | 0.77 | SOAT2 (0.58) | SOAT1SOAT2FAAHEPHX2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4370159-A2 | IONIZABLE LIPIDS, LIPID NANOPARTICLES FOR MRNA DELIVERY AND METHODS OF MAKING THE SAME | University of Cincinnati (US) | 2024-05-22 | — | — | EP | disclosed |
| WO-2024077232-A2 | COMPOSITIONS AND METHODS FOR T CELL TARGETED DELIVERY OF THERAPEUTIC AGENTS AND ACTIVATION OF T CELLS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2024-04-11 | — | — | WO | disclosed |
| WO-2023126404-A1 | LIPID-BASED FORMULATIONS FOR ADMINISTRATION OF RNA | BioNTech SE (DE) | 2023-07-06 | — | — | WO | disclosed |
| WO-2023126053-A1 | LIPID-BASED FORMULATIONS FOR ADMINISTRATION OF RNA | BioNTech SE (DE) | 2023-07-06 | — | — | WO | disclosed |
| WO-2023115221-A1 | IONIZABLE DILSULFIDE LIPIDS AND LIPID NANOPARTICLES DERIVED THEREFROM | PROVIDENCE THERAPEUTICS HOLDINGS INC. (CA) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023094713-A2 | CORONAVIRUS VACCINE | BioNTech SE (DE) | 2023-06-01 | — | — | WO | disclosed |
| WO-2023023410-A9 | IONIZABLE LIPIDS, LIPID NANOPARTICLES FOR MRNA DELIVERY AND METHODS OF MAKING THE SAME | UNIVERSITY OF CINCINNATI (US) | 2023-05-11 | — | — | WO | disclosed |
| WO-2023023410-A2 | IONIZABLE LIPIDS, LIPID NANOPARTICLES FOR MRNA DELIVERY AND METHODS OF MAKING THE SAME | UNIVERSITY OF CINCINNATI (US) | 2023-02-23 | — | — | WO | disclosed |
| EP-3972653-A1 | CIRCULAR RNA COMPOSITIONS AND METHODS | Massachusetts Institute of Technology (US) | 2022-03-30 | — | — | EP | disclosed |
| WO-2020237227-A1 | CIRCULAR RNA COMPOSITIONS AND METHODS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-11-26 | — | — | WO | disclosed |
| EP-3624824-A1 | TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF CODON-OPTIMIZED MRNA ENCODING CFTR | Translate Bio, Inc. (US) | 2020-03-25 | — | — | EP | disclosed |
| WO-2018213476-A1 | TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF CODON-OPTIMIZED MRNA ENCODING CFTR | TRANSLATE BIO, INC. (US) | 2018-11-22 | — | — | WO | disclosed |